Literature DB >> 21845597

Depression in Alzheimer's disease: specificity of depressive symptoms using three different clinical criteria.

Knut Engedal1, Maria Lage Barca, Jerson Laks, Geir Selbaek.   

Abstract

BACKGROUND: Previous studies report contradictory results on whether the symptoms of depression in Alzheimer's disease patients are the same as in cognitively normal persons. Thus, provisional criteria for depression in Alzheimer's disease (PDC-dAD) have been developed. AIM: To examine which symptoms in AD patients are significant in diagnosing depression according to PDC-dAD compared to those for the DSM-IV-TR and ICD-10 criteria.
METHODS: We included 112 patients with Alzheimer's disease. They were interviewed by a psychiatrist who diagnosed depression according to PDC-dAD, DSM-IV-TR and ICD-10. Without knowledge of that diagnosis, trained nurses interviewed the caregivers of the patients using the Cornell scale for depression in dementia (CSDD).
RESULTS: Mean age of the patients was 83.0 (s.d. 7.9), 77 (69.6%) were female. The proportion with depression according to each set of criteria was: PDC-dAD 53.5%, ICD-10, 47.3% and DSM-IV-TR, 34.8%. Sadness, loss of interest and agitation/retardation were the most prevalent symptoms in depressed subjects as evaluated by the psychiatrists. According to CSDD sadness, anxiety, suicidal thoughts, poor self-esteem, multiple physical complaints and pessimism best distinguished the depressed patients from the non-depressed. In multiple logistic regression analyses poor self-esteem, delusion and multiple physical complaints best predicted depression using PDC-dAD criteria, whereas sadness, suicidal thoughts and poor self-esteem best predicted depression using ICD-10 and DSM-IV-TR.
CONCLUSION: The most significant symptoms for a depressive disorder in AD are pretty much the same as for patients without dementia using the DSM-IV-TR and ICD-10 criteria, whereas they differ using the PDC-dAD criteria.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21845597     DOI: 10.1002/gps.2631

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  11 in total

Review 1.  Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology.

Authors:  Robert W Levenson; Virginia E Sturm; Claudia M Haase
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

Review 2.  Depression in dementia.

Authors:  David Kitching
Journal:  Aust Prescr       Date:  2015-12-01

3.  Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Authors:  Julia J Hsiao; Edmond Teng
Journal:  Neurodegener Dis Manag       Date:  2013

Review 4.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

5.  Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study.

Authors:  Julia Fiona-Maree Gilmartin; Saku Väätäinen; Soili Törmälehto; J Simon Bell; Eija Lönnroos; Lotta Salo; Ilona Hallikainen; Janne Martikainen; Anne M Koivisto
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

6.  Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.

Authors:  Eva Kitzlerová; Zdeněk Fišar; Petra Lelková; Roman Jirák; Martina Zvěřová; Jana Hroudová; Ada Manukyan; Pavel Martásek; Jiří Raboch
Journal:  Med Sci Monit       Date:  2018-04-28

7.  Differences in Cerebral Structure Associated With Depressive Symptoms in the Elderly With Alzheimer's Disease.

Authors:  Yue Wu; Xingqi Wu; Qiang Wei; Kai Wang; Yanghua Tian
Journal:  Front Aging Neurosci       Date:  2020-05-12       Impact factor: 5.750

8.  Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism.

Authors:  Xiaopeng Wang; Jing Zhao
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

9.  Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.

Authors:  Simon Forstmeier; Andreas Maercker
Journal:  BMC Psychiatry       Date:  2015-11-17       Impact factor: 3.630

10.  Sex-specific depressive symptoms as markers of pre-Alzheimer dementia: findings from the Three-City cohort study.

Authors:  Joanna Norton; Isabelle Carrière; Karine Pérès; Audrey Gabelle; Claudine Berr; Karen Ritchie; Marie-Laure Ancelin
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.